Calumet (NASDAQ:CLMT) Director Sells $274,600.00 in Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 20,000 shares of Calumet stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $13.73, for a total value of $274,600.00. Following the completion of the transaction, the director owned 141,959 shares of the company’s stock, valued at approximately $1,949,097.07. This trade represents a 12.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Calumet Price Performance

CLMT stock opened at $26.96 on Friday. The firm has a market capitalization of $2.34 billion, a P/E ratio of -69.13 and a beta of 1.24. The business’s 50-day moving average is $23.06 and its two-hundred day moving average is $19.95. Calumet, Inc. has a 1 year low of $7.68 and a 1 year high of $30.35.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The company had revenue of ($3,098.50) million for the quarter, compared to analyst estimates of $1.04 billion. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.47) earnings per share. On average, analysts expect that Calumet, Inc. will post -3.02 EPS for the current year.

Institutional Investors Weigh In On Calumet

Several large investors have recently modified their holdings of CLMT. Islay Capital Management LLC acquired a new position in shares of Calumet in the 4th quarter valued at $25,000. Aster Capital Management DIFC Ltd grew its position in Calumet by 294.7% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock worth $33,000 after purchasing an additional 1,229 shares during the last quarter. Global Retirement Partners LLC acquired a new position in Calumet in the fourth quarter valued at $34,000. Amalgamated Bank purchased a new stake in shares of Calumet in the second quarter valued at about $37,000. Finally, Covestor Ltd boosted its stake in shares of Calumet by 29.1% during the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after buying an additional 492 shares during the period. 34.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. HC Wainwright reaffirmed a “buy” rating and set a $33.00 price objective on shares of Calumet in a research report on Monday, November 10th. UBS Group reaffirmed a “neutral” rating and set a $26.00 price target on shares of Calumet in a report on Friday, February 13th. TD Cowen reaffirmed a “hold” rating on shares of Calumet in a research report on Thursday, January 29th. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $22.83.

Key Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: Q4 EPS beat — Calumet reported GAAP EPS of ($0.43) vs. consensus ($0.67), reducing downside surprise and supporting near‑term sentiment. Q4 2025 Results
• Positive Sentiment: FY2025 operational / cash‑flow improvements — management highlighted Adjusted EBITDA with tax attributes of $293.3M, ~$222M of recourse debt reduction, ~ $100M of cost savings driving free cash flow, and a Montana Renewables expansion on track for Q2 2026; these items materially lower financial risk and support valuation upside longer term. FY2025 Results & Commentary
• Neutral Sentiment: Analyst / preview coverage mixed — several firms updated targets and ratings (Goldman raised its PT; others remain hold/neutral), and the consensus price target (~$22.83) is below the recent trading level, leaving sentiment conflicted. Analyst Coverage Summary
• Negative Sentiment: Insider selling — Director Daniel J. Sajkowski disclosed multiple recent sales (including a recent 2,000‑share tranche and several 20k tranches earlier), materially trimming his stake; visible insider sales often weigh on investor confidence. Insider Trades Report
• Negative Sentiment: Rising short interest — short positions climbed in February to roughly 6.97M shares (~8.4% of float) with a ~4.4 days‑to‑cover, increasing the potential for continued selling pressure and intraday volatility. Short Interest Data

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.